| 1 |
Kalla S, Ellis RJ, Campbell SB, Doucet B, Isbel N, Tie B, Jegatheesan D. Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient. J Kidney Cancer VHL 2021;8:25-31. [PMID: 33850692 DOI: 10.15586/jkcvhl.v8i1.161] [Reference Citation Analysis]
|
| 2 |
Ozawa M, Ohtani H, Komatsuda A, Wakui H, Takahashi N. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience. Clin Exp Nephrol 2021. [PMID: 34115234 DOI: 10.1007/s10157-021-02090-z] [Reference Citation Analysis]
|
| 3 |
Nihei S, Asaka J, Takahashi H, Kudo K. Bevacizumab Increases Endothelin-1 Production via Forkhead Box Protein O1 in Human Glomerular Microvascular Endothelial Cells In Vitro. Int J Nephrol 2021;2021:8381115. [PMID: 34912580 DOI: 10.1155/2021/8381115] [Reference Citation Analysis]
|
| 4 |
Tanabe K, Wada J, Sato Y. Targeting angiogenesis and lymphangiogenesis in kidney disease. Nat Rev Nephrol 2020;16:289-303. [PMID: 32144398 DOI: 10.1038/s41581-020-0260-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 5 |
Van Wynsberghe M, Flejeo J, Sakhi H, Ollero M, Sahali D, Izzedine H, Henique C. Nephrotoxicity of Anti-Angiogenic Therapies. Diagnostics (Basel) 2021;11:640. [PMID: 33916159 DOI: 10.3390/diagnostics11040640] [Reference Citation Analysis]
|
| 6 |
Mizuno S, Kitayama C, Sanada S, Sato T. Bortezomib-induced glomerular microangiopathy complicated with monoclonal immunoglobulin deposition disease. CEN Case Rep 2021. [PMID: 33909224 DOI: 10.1007/s13730-021-00603-z] [Reference Citation Analysis]
|
| 7 |
Katsuno T, Ito Y, Kagami S, Kitamura H, Maruyama S, Shimizu A, Sugiyama H, Sato H, Yokoyama H, Kashihara N. A nationwide cross-sectional analysis of thrombotic microangiopathy in the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2020;24:789-97. [PMID: 32415379 DOI: 10.1007/s10157-020-01896-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Frazier KS. Kidney Effects by Alternative Classes of Medicines in Patients and Relationship to Effects in Nonclinical Toxicity Studies. Toxicol Pathol 2022;:1926233221100414. [PMID: 35608030 DOI: 10.1177/01926233221100414] [Reference Citation Analysis]
|
| 9 |
Demir F, Troldborg A, Thiel S, Lassé M, Huesgen PF, Tomas NM, Wiech T, Rinschen MM. Proteolysis and inflammation of the kidney glomerulus. Cell Tissue Res 2021. [PMID: 33864499 DOI: 10.1007/s00441-021-03433-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Touzani F, Geers C, Pozdzik A. Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury. Case Rep Nephrol 2019;2019:2919080. [PMID: 31934470 DOI: 10.1155/2019/2919080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 11 |
Gökyer A, Küçükarda A, Köstek O, Hacıoğlu MB, Uzunoğlu S, Kula O, Kurt N, Üstündağ S, Erdoğan B, Çiçin İ. Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study. Int J Clin Oncol 2020;25:1757-62. [PMID: 32591963 DOI: 10.1007/s10147-020-01729-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Ebrahimi M, Balibegloo M, Rezaei N. Monoclonal antibodies in diabetic retinopathy. Expert Rev Clin Immunol 2022. [PMID: 35105268 DOI: 10.1080/1744666X.2022.2037420] [Reference Citation Analysis]
|
| 13 |
Morimoto M, Arai T, Matsuura M, Ono Y. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer. CEN Case Rep 2021;10:6-11. [PMID: 32642991 DOI: 10.1007/s13730-020-00504-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
